I
Power Law company profile
InSilico Medicine
Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2025 Unicorn
Valuation
$4.07B
Market cap · Apr/2026
Revenue
$56M
Latest reported FY
Global footprint
Where InSilico Medicine has talent and traffic
AI talent share
4.6%
of workforce is AI talent
(13 of 285 staff)
(13 of 285 staff)
Core AI82.81%
Other AI51.75%
Non-AI workforce27295.44%
Web traffic by country
58K
monthly visits
across markets
across markets
🇺🇸 United States26%
🇦🇺 Australia10%
🇮🇳 India9.7%
🇬🇧 United Kingdom6.6%
🏳️ Korea6.2%
Patent intelligence
$18M patent portfolio · 166 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$18M
0.45% of market cap · comparable to top peer Sinovent ($17M)
166 active patent families
Where InSilico Medicine innovates
Pharmaceutical SubstancesPharmaceutical medicineCo carbon monoxideCarbon monoxide detectorSmoke Emission
Below peer median on Legal, Strategic, Market
Quality vs same-sector peers
InSilico Medicine on the five Patsnap quality dimensions
InSilico Medicine in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where InSilico Medicine concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across InSilico Medicine and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee InSilico Medicine on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.